139 related articles for article (PubMed ID: 12165396)
1. Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by D-penicillamine.
Rossi L; Squitti R; Pasqualetti P; Marchese E; Cassetta E; Forastiere E; Rotilio G; Rossini PM; Finazzi-Agró A
Neurosci Lett; 2002 Aug; 329(2):137-40. PubMed ID: 12165396
[TBL] [Abstract][Full Text] [Related]
2. Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives.
Serra JA; Famulari AL; Kohan S; Marschoff ER; Dominguez RO; de Lustig ES
J Neurol Sci; 1994 Apr; 122(2):179-88. PubMed ID: 8021702
[TBL] [Abstract][Full Text] [Related]
3. Mineral status and superoxide dismutase enzyme activity in Alzheimer's disease.
Rodrigues GP; Cozzolino SMF; Marreiro DDN; Caldas DRC; da Silva KG; de Sousa Almondes KG; Neto JMM; Pimentel JAC; de Carvalho CMRG; Nogueira NDN
J Trace Elem Med Biol; 2017 Dec; 44():83-87. PubMed ID: 28965606
[TBL] [Abstract][Full Text] [Related]
4. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease.
Vural H; Demirin H; Kara Y; Eren I; Delibas N
J Trace Elem Med Biol; 2010 Jul; 24(3):169-73. PubMed ID: 20569929
[TBL] [Abstract][Full Text] [Related]
5. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
Iskra M; Majewski W
Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
[TBL] [Abstract][Full Text] [Related]
6. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
7. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging.
de Lustig ES; Serra JA; Kohan S; Canziani GA; Famulari AL; Dominguez RO
J Neurol Sci; 1993 Mar; 115(1):18-25. PubMed ID: 8468588
[TBL] [Abstract][Full Text] [Related]
8. Effect of high dietary zinc on plasma ceruloplasmin and erythrocyte superoxide dismutase activities in copper-depleted and repleted rats.
Panemangalore M; Bebe FN
Biol Trace Elem Res; 1996; 55(1-2):111-26. PubMed ID: 8971359
[TBL] [Abstract][Full Text] [Related]
9. Zinc treatment affects superoxide dismutase activity in growth retardation.
Kocatürk PA; Siklar Z; Kavas GO; Dallar Y; Tanyer G
Biol Trace Elem Res; 2002; 90(1-3):39-46. PubMed ID: 12666824
[TBL] [Abstract][Full Text] [Related]
10. Superoxide dismutase activity and zinc and copper concentrations in growth retardation.
Kocatürk PA; Kavas GO; Erdeve O; Siklar Z
Biol Trace Elem Res; 2004; 102(1-3):51-9. PubMed ID: 15621927
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term penicillamine therapy on erythrocyte CuZn superoxide dismutase activity.
Marklund SL; Ek B; Steen L
Scand J Clin Lab Invest; 1984 Feb; 44(1):13-7. PubMed ID: 6701446
[TBL] [Abstract][Full Text] [Related]
12. Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs.
Iskra M; Majewski W
Int J Clin Lab Res; 1999; 29(2):64-7. PubMed ID: 10436263
[TBL] [Abstract][Full Text] [Related]
13. Change of zinc, copper, and metallothionein concentrations and the copper-zinc superoxide dismutase activity in patients with pancreatitis.
Milnerowicz H; Jabłonowska M; Bizoń A
Pancreas; 2009 Aug; 38(6):681-8. PubMed ID: 19629005
[TBL] [Abstract][Full Text] [Related]
14. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study.
Ozcankaya R; Delibas N
Croat Med J; 2002 Feb; 43(1):28-32. PubMed ID: 11828555
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
[TBL] [Abstract][Full Text] [Related]
16. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia.
Ihara Y; Hayabara T; Sasaki K; Fujisawa Y; Kawada R; Yamamoto T; Nakashima Y; Yoshimune S; Kawai M; Kibata M; Kuroda S
J Neurol Sci; 1997 Dec; 153(1):76-81. PubMed ID: 9455982
[TBL] [Abstract][Full Text] [Related]
17. Copper and zinc in stage I multiple myeloma: relation with ceruloplasmin, lipid peroxidation, and superoxide dismutase activity.
Khadem-Ansari MH; Asoudeh M; Gheshlaghi HFK; Nozari S; Zarringol M; Maroufi NF; Faridvand Y
Horm Mol Biol Clin Investig; 2018 Oct; 37(3):. PubMed ID: 30367794
[TBL] [Abstract][Full Text] [Related]
18. d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.
Squitti R; Rossini PM; Cassetta E; Moffa F; Pasqualetti P; Cortesi M; Colloca A; Rossi L; Finazzi-Agró A
Eur J Clin Invest; 2002 Jan; 32(1):51-9. PubMed ID: 11851727
[TBL] [Abstract][Full Text] [Related]
19. Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus.
Williams NR; Rajput-Williams J; West JA; Nigdikar SV; Foote JW; Howard AN
Analyst; 1995 Mar; 120(3):887-90. PubMed ID: 7741248
[TBL] [Abstract][Full Text] [Related]
20. Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study.
Perrin R; Briançon S; Jeandel C; Artur Y; Minn A; Penin F; Siest G
Gerontology; 1990; 36(5-6):306-13. PubMed ID: 2076828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
